Table of Contents 1 Study Coverage 1.1 Choroidal Neovascularization Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Choroidal Neovascularization Market Size Growth Rate by Product 1.4.2 Intravenous 1.4.3 Intravitreal 1.5 Market by End User 1.5.1 Global Choroidal Neovascularization Market Size Growth Rate by End User 1.5.2 Extreme Myopia 1.5.3 Malignant Myopic Degeneration 1.5.4 Age-Related Developments 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Choroidal Neovascularization Market Size 2.1.1 Global Choroidal Neovascularization Revenue 2014-2025 2.1.2 Global Choroidal Neovascularization Sales 2014-2025 2.2 Choroidal Neovascularization Growth Rate by Regions 2.2.1 Global Choroidal Neovascularization Sales by Regions 2.2.2 Global Choroidal Neovascularization Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Choroidal Neovascularization Sales by Manufacturers 3.1.1 Choroidal Neovascularization Sales by Manufacturers 3.1.2 Choroidal Neovascularization Sales Market Share by Manufacturers 3.1.3 Global Choroidal Neovascularization Market Concentration Ratio (CR5 and HHI) 3.2 Choroidal Neovascularization Revenue by Manufacturers 3.2.1 Choroidal Neovascularization Revenue by Manufacturers (2014-2019) 3.2.2 Choroidal Neovascularization Revenue Share by Manufacturers (2014-2019) 3.3 Choroidal Neovascularization Price by Manufacturers 3.4 Choroidal Neovascularization Manufacturing Base Distribution, Product Types 3.4.1 Choroidal Neovascularization Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Choroidal Neovascularization Product Type 3.4.3 Date of International Manufacturers Enter into Choroidal Neovascularization Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Choroidal Neovascularization Sales by Product 4.2 Global Choroidal Neovascularization Revenue by Product 4.3 Choroidal Neovascularization Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Choroidal Neovascularization Breakdown Data by End User 6 North America 6.1 North America Choroidal Neovascularization by Countries 6.1.1 North America Choroidal Neovascularization Sales by Countries 6.1.2 North America Choroidal Neovascularization Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Choroidal Neovascularization by Product 6.3 North America Choroidal Neovascularization by End User 7 Europe 7.1 Europe Choroidal Neovascularization by Countries 7.1.1 Europe Choroidal Neovascularization Sales by Countries 7.1.2 Europe Choroidal Neovascularization Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Choroidal Neovascularization by Product 7.3 Europe Choroidal Neovascularization by End User 8 Asia Pacific 8.1 Asia Pacific Choroidal Neovascularization by Countries 8.1.1 Asia Pacific Choroidal Neovascularization Sales by Countries 8.1.2 Asia Pacific Choroidal Neovascularization Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Choroidal Neovascularization by Product 8.3 Asia Pacific Choroidal Neovascularization by End User 9 Central & South America 9.1 Central & South America Choroidal Neovascularization by Countries 9.1.1 Central & South America Choroidal Neovascularization Sales by Countries 9.1.2 Central & South America Choroidal Neovascularization Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Choroidal Neovascularization by Product 9.3 Central & South America Choroidal Neovascularization by End User 10 Middle East and Africa 10.1 Middle East and Africa Choroidal Neovascularization by Countries 10.1.1 Middle East and Africa Choroidal Neovascularization Sales by Countries 10.1.2 Middle East and Africa Choroidal Neovascularization Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Choroidal Neovascularization by Product 10.3 Middle East and Africa Choroidal Neovascularization by End User 11 Company Profiles 11.1 Pfizer Inc. 11.1.1 Pfizer Inc. Company Details 11.1.2 Company Business Overview 11.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Pfizer Inc. Choroidal Neovascularization Products Offered 11.1.5 Pfizer Inc. Recent Development 11.2 F. Hoffmann-La Roche Ltd. 11.2.1 F. Hoffmann-La Roche Ltd. Company Details 11.2.2 Company Business Overview 11.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Products Offered 11.2.5 F. Hoffmann-La Roche Ltd. Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Company Business Overview 11.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Novartis AG Choroidal Neovascularization Products Offered 11.3.5 Novartis AG Recent Development 11.4 Regeneron Pharmaceuticals Inc. 11.4.1 Regeneron Pharmaceuticals Inc. Company Details 11.4.2 Company Business Overview 11.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Products Offered 11.4.5 Regeneron Pharmaceuticals Inc. Recent Development 11.5 Bayer AG 11.5.1 Bayer AG Company Details 11.5.2 Company Business Overview 11.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Bayer AG Choroidal Neovascularization Products Offered 11.5.5 Bayer AG Recent Development 11.6 QLT Inc. 11.6.1 QLT Inc. Company Details 11.6.2 Company Business Overview 11.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.6.4 QLT Inc. Choroidal Neovascularization Products Offered 11.6.5 QLT Inc. Recent Development 11.7 Sanwa Kagaku Kenkyusho Co. Ltd. 11.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Company Details 11.7.2 Company Business Overview 11.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Products Offered 11.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development 11.8 Promedior Inc. 11.8.1 Promedior Inc. Company Details 11.8.2 Company Business Overview 11.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Promedior Inc. Choroidal Neovascularization Products Offered 11.8.5 Promedior Inc. Recent Development 11.9 Valeant Pharmaceuticals International Inc. 11.9.1 Valeant Pharmaceuticals International Inc. Company Details 11.9.2 Company Business Overview 11.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Products Offered 11.9.5 Valeant Pharmaceuticals International Inc. Recent Development 11.10 Gilead Sciences Inc 11.10.1 Gilead Sciences Inc Company Details 11.10.2 Company Business Overview 11.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Gilead Sciences Inc Choroidal Neovascularization Products Offered 11.10.5 Gilead Sciences Inc Recent Development 12 Future Forecast 12.1 Choroidal Neovascularization Market Forecast by Regions 12.1.1 Global Choroidal Neovascularization Sales Forecast by Regions 2019-2025 12.1.2 Global Choroidal Neovascularization Revenue Forecast by Regions 2019-2025 12.2 Choroidal Neovascularization Market Forecast by Product 12.2.1 Global Choroidal Neovascularization Sales Forecast by Product 2019-2025 12.2.2 Global Choroidal Neovascularization Revenue Forecast by Product 2019-2025 12.3 Choroidal Neovascularization Market Forecast by End User 12.4 North America Choroidal Neovascularization Forecast 12.5 Europe Choroidal Neovascularization Forecast 12.6 Asia Pacific Choroidal Neovascularization Forecast 12.7 Central & South America Choroidal Neovascularization Forecast 12.8 Middle East and Africa Choroidal Neovascularization Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Choroidal Neovascularization Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Choroidal Neovascularization Product Picture Table Choroidal Neovascularization Market Segments Table Key Manufacturers Choroidal Neovascularization Covered Table Global Choroidal Neovascularization Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Choroidal Neovascularization Sales Market Share by Product 2014-2025 Figure Intravenous Product Picture Table Major Manufacturers of Intravenous Figure Intravitreal Product Picture Table Major Manufacturers of Intravitreal Table Global Choroidal Neovascularization Market Size Growth Rate by End User 2019-2025 (K Units) Figure Extreme Myopia Figure Malignant Myopic Degeneration Figure Age-Related Developments Figure Choroidal Neovascularization Report Years Considered Figure Global Choroidal Neovascularization Market Size 2014-2025 (Million US$) Figure Global Choroidal Neovascularization Sales 2014-2025 (K Units) Table Global Choroidal Neovascularization Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Choroidal Neovascularization Sales by Regions 2014-2019 (K Units) Table Global Choroidal Neovascularization Sales Market Share by Regions 2014-2019 Figure Global Choroidal Neovascularization Sales Market Share by Regions 2014-2019 Figure 2018 Global Choroidal Neovascularization Sales Market Share by Regions Table Global Choroidal Neovascularization Revenue by Regions 2014-2019 (Million US$) Table Global Choroidal Neovascularization Revenue Market Share by Regions 2014-2019 Figure Global Choroidal Neovascularization Revenue Market Share by Regions 2014-2019 Figure 2018 Global Choroidal Neovascularization Revenue Market Share by Regions Table Global Choroidal Neovascularization Sales by Manufacturers (2014-2019) (K Units) Table Global Choroidal Neovascularization Sales Share by Manufacturers (2014-2019) Figure Global Choroidal Neovascularization Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Choroidal Neovascularization Revenue by Manufacturers (2014-2019) (Million USD) Table Choroidal Neovascularization Revenue Share by Manufacturers (2014-2019) Figure Choroidal Neovascularization Value Share by Manufacturers in 2018 Table Key Manufacturers Choroidal Neovascularization Price (2014-2019) (USD/Unit) Table Choroidal Neovascularization Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Choroidal Neovascularization Product Type Table Date of International Manufacturers Enter into Choroidal Neovascularization Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table Global Choroidal Neovascularization Sales Share by Product (2014-2019) Figure Global Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure Global Choroidal Neovascularization Sales Market Share by Product in 2018 Table Global Choroidal Neovascularization Revenue by Product (2014-2019) (Million US$) Table Global Choroidal Neovascularization Revenue Share by Product (2014-2019) Figure Global Choroidal Neovascularization Revenue Market Share by Product (2014-2019) Figure Global Choroidal Neovascularization Revenue Market Share by Product in 2018 Table Choroidal Neovascularization Price by Product 2014-2019 (USD/Unit) Table Global Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table Global Choroidal Neovascularization Sales Share by End User (2014-2019) Figure Global Sales Choroidal Neovascularization Market Share by End User (2014-2019) Figure Global Sales Choroidal Neovascularization Market Share by End User in 2018 Figure North America Choroidal Neovascularization Sales Growth Rate 2014-2019 (K Units) Figure North America Choroidal Neovascularization Revenue Growth Rate 2014-2019 (Million US$) Table North America Choroidal Neovascularization Sales by Countries (2014-2019) (K Units) Table North America Choroidal Neovascularization Sales Market Share by Countries (2014-2019) Figure 2018 North America Choroidal Neovascularization Sales Market Share by Countries Table North America Choroidal Neovascularization Revenue by Countries (2014-2019) (Million US$) Table North America Choroidal Neovascularization Revenue Market Share by Countries (2014-2019) Figure 2018 North America Choroidal Neovascularization Revenue Market Share by Countries Figure United States Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure United States Choroidal Neovascularization Revenue Growth Rate (2014-2019) (K Units) Figure Canada Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Canada Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Mexico Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Table North America Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table North America Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure 2018 North America Choroidal Neovascularization Market Share by Product Table North America Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table North America Choroidal Neovascularization Sales Market Share by End User (2014-2019) Figure 2018 North America Choroidal Neovascularization Market Share by End User Figure Europe Choroidal Neovascularization Sales Growth Rate 2014-2019 (K Units) Figure Europe Choroidal Neovascularization Revenue Growth Rate 2014-2019 (Million US$) Table Europe Choroidal Neovascularization Sales by Countries (2014-2019) (K Units) Table Europe Choroidal Neovascularization Sales Market Share by Countries (2014-2019) Figure 2018 Europe Choroidal Neovascularization Sales Market Share by Countries Table Europe Choroidal Neovascularization Revenue by Countries (2014-2019) (Million US$) Table Europe Choroidal Neovascularization Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Choroidal Neovascularization Revenue Market Share by Countries Figure Germany Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Germany Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure France Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure France Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure UK Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure UK Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Italy Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Russia Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Table Europe Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table Europe Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure 2018 Europe Choroidal Neovascularization Market Share by Product Table Europe Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table Europe Choroidal Neovascularization Sales Market Share by End User (2014-2019) Figure 2018 Europe Choroidal Neovascularization Market Share by End User Figure Asia Pacific Choroidal Neovascularization Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Choroidal Neovascularization Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Choroidal Neovascularization Sales by Countries (2014-2019) (K Units) Table Asia Pacific Choroidal Neovascularization Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Choroidal Neovascularization Sales Market Share by Countries Table Asia Pacific Choroidal Neovascularization Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Choroidal Neovascularization Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Choroidal Neovascularization Revenue Market Share by Countries Figure China Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure China Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Japan Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Korea Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure India Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure India Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Australia Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Philippines Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Thailand Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Singapore Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table Asia Pacific Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Choroidal Neovascularization Market Share by Product Table Asia Pacific Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table Asia Pacific Choroidal Neovascularization Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Choroidal Neovascularization Market Share by End User Figure Central & South America Choroidal Neovascularization Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Choroidal Neovascularization Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Choroidal Neovascularization Sales by Countries (2014-2019) (K Units) Table Central & South America Choroidal Neovascularization Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Choroidal Neovascularization Sales Market Share by Countries Table Central & South America Choroidal Neovascularization Revenue by Countries (2014-2019) (Million US$) Table Central & South America Choroidal Neovascularization Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Choroidal Neovascularization Revenue Market Share by Countries Figure Brazil Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Brazil Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Argentina Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table Central & South America Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Choroidal Neovascularization Market Share by Product Table Central & South America Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table Central & South America Choroidal Neovascularization Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Choroidal Neovascularization Market Share by End User Figure Middle East and Africa Choroidal Neovascularization Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Choroidal Neovascularization Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Choroidal Neovascularization Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Choroidal Neovascularization Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Choroidal Neovascularization Sales Market Share by Countries Table Middle East and Africa Choroidal Neovascularization Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Choroidal Neovascularization Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Choroidal Neovascularization Revenue Market Share by Countries Figure GCC Countries Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Turkey Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure Egypt Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Choroidal Neovascularization Sales Growth Rate (2014-2019) (K Units) Figure South Africa Choroidal Neovascularization Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Choroidal Neovascularization Sales by Product (2014-2019) (K Units) Table Middle East and Africa Choroidal Neovascularization Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Choroidal Neovascularization Market Share by Product Table Middle East and Africa Choroidal Neovascularization Sales by End User (2014-2019) (K Units) Table Middle East and Africa Choroidal Neovascularization Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Choroidal Neovascularization Market Share by End User Table Pfizer Inc. Company Details Table Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc. Recent Development Table F. Hoffmann-La Roche Ltd. Company Details Table F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table F. Hoffmann-La Roche Ltd. Recent Development Table Novartis AG Company Details Table Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG Recent Development Table Regeneron Pharmaceuticals Inc. Company Details Table Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Regeneron Pharmaceuticals Inc. Recent Development Table Bayer AG Company Details Table Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer AG Recent Development Table QLT Inc. Company Details Table QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table QLT Inc. Recent Development Table Sanwa Kagaku Kenkyusho Co. Ltd. Company Details Table Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development Table Promedior Inc. Company Details Table Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Promedior Inc. Recent Development Table Valeant Pharmaceuticals International Inc. Company Details Table Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Valeant Pharmaceuticals International Inc. Recent Development Table Gilead Sciences Inc Company Details Table Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead Sciences Inc Recent Development Table Global Choroidal Neovascularization Sales Forecast by Regions 2019-2025 (K Units) Table Global Choroidal Neovascularization Sales Market Share Forecast by Regions 2019-2025 Table Global Choroidal Neovascularization Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Choroidal Neovascularization Revenue Market Share Forecast by Regions 2019-2025 Table Global Choroidal Neovascularization Sales Forecast by Product 2019-2025 (K Units) Table Global Choroidal Neovascularization Sales Market Share Forecast by Product 2019-2025 Table Global Choroidal Neovascularization Revenue Forecast by Product 2019-2025 (Million US$) Table Global Choroidal Neovascularization Revenue Market Share Forecast by Product 2019-2025 Table Global Choroidal Neovascularization Sales Forecast by End User 2019-2025 (K Units) Table Global Choroidal Neovascularization Sales Market Share Forecast by End User 2019-2025 Figure North America Choroidal Neovascularization Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Choroidal Neovascularization Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Choroidal Neovascularization Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Choroidal Neovascularization Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Choroidal Neovascularization Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Choroidal Neovascularization Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Choroidal Neovascularization Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Choroidal Neovascularization Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Choroidal Neovascularization Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Choroidal Neovascularization Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Choroidal Neovascularization Value Chain Table Choroidal Neovascularization Customers List Table Choroidal Neovascularization Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Inc. F. Hoffmann-La Roche Ltd. Novartis AG Regeneron Pharmaceuticals Inc. Bayer AG QLT Inc. Sanwa Kagaku Kenkyusho Co. Ltd. Promedior Inc. Valeant Pharmaceuticals International Inc. Gilead Sciences Inc